Honeywell Aerospace Inc. heads into its August 14 earnings event carrying the full weight of a brutal Q2 miss — and options traders are more anxious ahead of this print than at any point in the past year.
The clearest signal heading into Thursday's release is in options positioning. The put/call ratio has climbed to 0.76, nearly three standard deviations above its 20-day average of 0.53 — the highest reading in HONA's short history as a public company. That is a sharp escalation from the mildly cautious setup that preceded the Q2 print, where the PCR was running at just 0.52 with a z-score of 0.60. The stock itself has recovered just 1.7% on Tuesday but remains down 23% on the week and 25% on the month, still reeling from the 27.7% single-day collapse that followed the Q2 report on August 5. The borrow market, by contrast, is entirely relaxed — availability is running at roughly 2,700%, meaning lenders hold around 27 shares for every one currently shorted. Cost to borrow has ticked up 47% on the week but remains negligible at 0.44%. Short sellers are not pressing a crowded bet here.
The debate among analysts has shifted entirely from initiation excitement to damage assessment. Every firm that launched coverage between late June and late July — JP Morgan, Morgan Stanley, UBS, BMO Capital, and others — has now revisited their targets. BMO's Daniel DiCicco, the lone bull at initiation, cut his target from $276 to $209 while holding his Outperform rating. RBC slashed from $300 to $250, retaining Outperform. UBS and BNP Paribas both trimmed to around $210-$213 at Neutral. The consensus mean now sits at $225, implying roughly 36% upside from Tuesday's close at $165.93 — but that gap is a product of the stock's collapse, not fresh conviction. Bulls point to the full-year adjusted EPS guidance raise to $7.60–$7.90 and the 5.4% revenue growth in Q2 as evidence that the underlying franchise is intact. Bears argue that a 32% year-on-year EPS collapse in the company's first quarter as a standalone public company has raised fundamental questions about margin recovery that management has not yet answered. On a PE basis, the multiple has compressed to roughly 18.8x trailing earnings, down about 4.4 points on the month — a meaningful re-rating, though the limited public history makes historical context difficult to establish.
The institutional ownership picture is worth noting for a company just months removed from its spin-off. BlackRock holds 7.5% and Invesco another 3.5%, with both positions reported as new since the listing. These are not speculative holders. Meanwhile, insider activity around the print has been routine — the CEO and an SVP sold small quantities near $204-$208 in late July and early August, following award grants, all at significance scores of 1 out of 10. No meaningful insider conviction in either direction.
Thursday's print is therefore less a question of whether HONA can grow and more a question of whether management can demonstrate that the Q2 margin compression was a transitional episode rather than a structural condition — and whether the company's full-year guidance upgrade holds any credibility after being set in the immediate aftermath of a miss.
See the live data behind this article on ORTEX.
Open HONA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
